Projects funded by the NCN
First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search for therapies for psychiatric disorders
2021/41/B/NZ7/04275
Keywords:
5-HT1A receptor D2 receptor functional selectivity biased agonism multimodal ligands schizophrenia medicinal chemistry
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 17
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 2 991 854 PLN
Project start date (Y-m-d): 2022-02-07
Project end date (Y-m-d): 2026-02-06
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.